BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15468379)

  • 1. Vasculitis associated with the use of leflunomide.
    Macdonald J; Zhong T; Lazarescu A; Gan BS; Harth M
    J Rheumatol; 2004 Oct; 31(10):2076-8. PubMed ID: 15468379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis.
    Laborde F; Loeuille D; Chary-Valckenaere I
    Arthritis Rheum; 2004 Oct; 50(10):3398. PubMed ID: 15476234
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide-associated weight loss in rheumatoid arthritis.
    Coblyn JS; Shadick N; Helfgott S
    Arthritis Rheum; 2001 May; 44(5):1048-51. PubMed ID: 11352235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
    Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 7. Leflunomide for active rheumatoid arthritis.
    Bruyn GA; Griep EN; Korff KJ
    Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359439
    [No Abstract]   [Full Text] [Related]  

  • 8. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
    Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E
    Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathy associated with leflunomide: a case series.
    Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
    Ann Rheum Dis; 2005 Apr; 64(4):649-50. PubMed ID: 15769926
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral neuropathy associated with leflunomide: is there a risk patient profile?
    Martin K; Bentaberry F; Dumoulin C; Miremont-Salamé G; Haramburu F; Dehais J; Schaeverbeke T
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):74-8. PubMed ID: 16845649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide.
    Gottenberg JE; Venancie PY; Mariette X
    J Rheumatol; 2002 Aug; 29(8):1806-7. PubMed ID: 12180755
    [No Abstract]   [Full Text] [Related]  

  • 12. Leflunomide-associated tuberculosis?
    Hocevar A; Rozman B; Praprotnik S; Lestan B; Erzen D; Petric V; Tomsic M
    Rheumatology (Oxford); 2006 Feb; 45(2):228-9. PubMed ID: 16319103
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy.
    Knab J; Goos M; Dissemond J
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):243-6. PubMed ID: 15752303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M; Creemers MC; Welsing PM; van Riel PL
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leflunomide for therapy of rheumatoid arthritis].
    Nakajima A; Yamanaka H
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():493-7. PubMed ID: 15799405
    [No Abstract]   [Full Text] [Related]  

  • 16. Weekly leflunomide as monotherapy for recent-onset rheumatoid arthritis.
    Jakez-Ocampo J; Richaud-Patin Y; Granados J; Sánchez-Guerrero J; Llorente L
    Arthritis Rheum; 2004 Feb; 51(1):147-8. PubMed ID: 14872469
    [No Abstract]   [Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Kerr OA; Murray CS; Tidman MJ
    Clin Exp Dermatol; 2004 May; 29(3):319-20. PubMed ID: 15115526
    [No Abstract]   [Full Text] [Related]  

  • 18. Leflunomide and warfarin interaction: case report and review of the literature.
    Chonlahan J; Halloran MA; Hammonds A
    Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide for active rheumatoid arthritis.
    Ferraccioli GF; De Vita S
    Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359440
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
    Perdriger A; Mariette X; Kuntz JL; Brocq O; Kara-Terki R; Loet XL; Cantagrel A; Pavy S; Deslandre CJ; Debiais F; Combe B;
    J Rheumatol; 2006 May; 33(5):865-9. PubMed ID: 16652418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.